Severe Hyponatremia After a Medication Change

Learning objectives#

• Distinguish true hypotonic hyponatremia from hypertonic, isotonic, and laboratory-artifact presentations.
• Treat severe neurologic symptoms promptly while the cause and chronicity remain under investigation.
• Interpret urine osmolality and urine sodium in the context of diuretics, volume status, endocrine disease, and recent fluid exposure.
• Anticipate overly rapid correction when a reversible antidiuretic stimulus resolves and a water diuresis begins.
• Build a medication-safety and follow-up plan that prevents re-exposure and catches electrolyte injury after future treatment changes.

Initial presentation#

The analysis opens with Ruth, a 72-year-old woman brought to the emergency department by her neighbor because she has become confused and unsteady. That morning, the neighbor found her sitting on the kitchen floor trying to put a shoe on her hand. Ruth had vomited twice and complained of a severe headache. During transport she became briefly difficult to arouse but did not have a witnessed generalized convulsion.

Twelve days earlier, a thiazide-like diuretic was added for persistent hypertension. At that visit, the blood pressure reading had been high after Ruth hurried through traffic. Her previous sodium was 138 mmol/L and potassium 4.0 mmol/L. She was advised to reduce salt and "drink plenty of water." Taking the instruction literally, she began carrying a large bottle and refilling it several times daily. Hot weather and a recent dental procedure reduced her appetite. For much of the week she ate tea, fruit, soup, and small portions of toast.

Her history includes hypertension, osteoarthritis, depression, and osteoporosis. She has taken a selective serotonin reuptake inhibitor at the same dose for four years. She uses no antiepileptic medicine. She has no known heart failure, cirrhosis, chronic kidney disease, adrenal disease, thyroid disease, or cancer. She does not drink alcohol. Her neighbor brings the medication bottles, including the new diuretic, the antidepressant, an angiotensin receptor blocker, and an occasional nonsteroidal anti-inflammatory drug. Pill counts suggest the new medicine was taken as prescribed. There is no desmopressin bottle and no evidence of recreational drug use.

The neighbor reports three days of increasing nausea, fatigue, and slowed conversation. Ruth called the clinic the previous afternoon but could not obtain a same-day appointment. She was offered a virtual visit for the following week. No electrolyte test had been arranged after the medication change. The neighbor also noticed that Ruth was making frequent trips to the bathroom early in the week but very little urine on the day before admission.

On arrival, temperature is 36.5 C, blood pressure 96/58 mm Hg while supine, pulse 84 per minute, respiratory rate 18 per minute, and oxygen saturation 97 percent on room air. She opens her eyes to voice, answers her first name, and cannot identify the month. Mucous membranes are dry. Neck veins are not elevated, lungs are clear, and there is no edema. The abdomen is soft. She moves all limbs without a clear focal deficit, but cannot sustain attention for a full examination. There is no neck stiffness or external evidence of major trauma.

Point-of-care glucose is normal. The first chemistry panel reports sodium 109 mmol/L, potassium 2.9 mmol/L, chloride 74 mmol/L, bicarbonate 24 mmol/L, urea mildly increased, and creatinine slightly above baseline. A trainee proposes one liter of isotonic crystalloid, stopping the diuretic, and repeating the sodium in the morning. That plan underestimates the neurologic emergency, assumes the mechanism before measuring tonicity and urine indices, and provides no protection against an abrupt water diuresis.

Problem representation#

This is an older adult with previously normal sodium, a newly started thiazide-like diuretic, increased water intake, reduced dietary solute, nausea, possible extracellular volume depletion, and progressive encephalopathy with a sodium of 109 mmol/L and hypokalemia. Symptom evolution over several days suggests the hyponatremia is not confidently acute within 48 hours, so brain adaptation and osmotic demyelination risk must be assumed even though severe cerebral symptoms require an immediate controlled rise.

The leading formulation is severe symptomatic hypotonic hyponatremia related to a recent thiazide exposure, with contributions from low solute intake, water intake, nausea-driven antidiuresis, and possibly the long-standing antidepressant. The physiology may resemble SIADH even if thiazide exposure is central. Dry mucosa and low blood pressure suggest volume depletion, but bedside volume classification is imperfect and diuretics disrupt usual urine-sodium interpretation.

Two hazards coexist. Untreated hyponatremic encephalopathy can progress to seizure, respiratory arrest, herniation, or death. Excessively rapid correction, particularly after several days of profound hyponatremia with hypokalemia and low intake, can cause osmotic demyelination. Safe care does not choose one hazard and ignore the other. It aims for a small prompt improvement in tonicity, then tightly controls the rest of the trajectory.

Prioritized differential#

Thiazide-associated hypotonic hyponatremia#

The timing, age, new exposure, hypokalemia, reduced intake, and water consumption strongly support this diagnosis. Thiazides impair urinary dilution while causing sodium and potassium loss. Susceptibility varies, and cases can present soon after initiation or later when another illness disrupts a previously stable balance. Some patients appear volume depleted; others show a biochemical pattern that resembles SIADH.

The medicine is associated with the event, but causation should not be declared solely from timing. Adrenal insufficiency, thyroid disease, kidney disease, a central nervous system process, or occult malignancy could coexist. The trajectory after withdrawal and correction of contributing factors adds evidence.

SIADH or medication-amplified antidiuresis#

Nausea is a potent stimulus for arginine vasopressin. Selective serotonin reuptake inhibitors and several other medicines can contribute to inappropriate water retention. SIADH requires hypotonic hyponatremia, urine that is not maximally dilute, relative clinical euvolemia, adequate kidney function, and exclusion of adrenal and thyroid insufficiency and relevant diuretic effects. Calling this pure SIADH while a thiazide is active would be premature.

Hypovolemic hyponatremia#

Dry mucosa, low blood pressure, reduced intake, and diuretic-related salt loss support low effective circulating volume. Baroreceptor-mediated vasopressin can prevent free-water excretion despite hypotonicity. Isotonic fluid may remove that stimulus, but it can also trigger a sudden water diuresis and rapid correction. A fixed large infusion without close monitoring is therefore unsafe in profound chronicity-unknown hyponatremia.

Low-solute intake with water excess#

The recent diet supplies limited protein and salt while water intake increased. Low osmole excretion restricts the kidney's capacity to excrete water. Pure low-solute hyponatremia often produces a very dilute urine once vasopressin is suppressed, but nausea, volume depletion, and medication effects can keep urine concentrated. Restoring nutrition can itself accelerate correction and must be included in the plan.

Adrenal insufficiency#

Cortisol deficiency can produce hyponatremia through persistent vasopressin activity. Primary adrenal insufficiency may also cause volume depletion, hyperkalemia, abdominal symptoms, and hypotension, although Ruth is hypokalemic. Secondary adrenal insufficiency can occur without hyperkalemia. Cortisol testing is important, and suspected adrenal crisis requires treatment without waiting for confirmatory testing.

Severe hypothyroidism#

Profound hypothyroidism can contribute to impaired water excretion, although mild thyroid-stimulating hormone abnormalities during illness should not be used as a convenient explanation. Thyroid testing is appropriate, but common subclinical abnormalities rarely explain sodium of 109 mmol/L by themselves.

Hypervolemic hyponatremia#

Heart failure, cirrhosis, and advanced kidney disease lower effective arterial volume despite increased total body water. Clear lungs, absent edema and ascites, and the recent history make these less likely. Echocardiography or liver evaluation should follow actual clues rather than become routine for every low sodium result.

Nonhypotonic hyponatremia or laboratory artifact#

Marked hyperglycemia or another effective osmole can draw water extracellularly and lower measured sodium while tonicity is normal or high. Severe hyperlipidemia or hyperproteinemia can cause pseudohyponatremia with some indirect laboratory methods. Normal glucose does not by itself exclude every nonhypotonic cause, so measured serum osmolality and laboratory method matter.

Acute neurologic disease causing symptoms or hyponatremia#

Intracranial hemorrhage, infection, stroke, seizure, and head trauma can cause confusion and may trigger SIADH. The absence of a focal deficit does not fully exclude them. The temporal history and profound sodium provide a coherent explanation, but failure to improve as sodium rises, a focal finding, fever, trauma, or seizure would prompt urgent neuroimaging or lumbar-puncture reasoning as appropriate.

Focused history and examination#

The focused history asks why sodium fell, how quickly it fell, how the brain is responding, and what may make correction dangerous.

• Neurologic severity: Clarify headache, vomiting, confusion, agitation, somnolence, falls, seizure activity, respiratory change, and timing. Repeat consciousness, pupils, speech, strength, and seizure observation frequently.
• Chronicity: Retrieve every recent sodium result and reconstruct the last known normal cognition. In community presentations, exact onset is often unknowable, so a low-risk assumption about chronicity is safer after initial symptom rescue.
• Fluid and solute: Quantify water, tea, alcohol, enteral intake, protein, salt, vomiting, diarrhea, sweating, urine frequency, and any recent advice that changed behavior. "Drinking normally" is too vague.
• Medication timeline: Record the exact start, stop, and dose-change dates for thiazides, antidepressants, antiepileptics, antipsychotics, desmopressin, chemotherapy, opioids, nonsteroidal anti-inflammatory drugs, and other contributors. Ask about bowel preparations and intravenous fluids.
• Volume and organ disease: Ask about thirst, orthostasis, edema, orthopnea, ascites, liver disease, kidney disease, and heart failure. Examine neck veins, lungs, edema, ascites, mucosa, perfusion, and postural response when safe.
• Endocrine clues: Ask about glucocorticoid exposure or withdrawal, autoimmune disease, weight loss, hyperpigmentation, salt craving, hypoglycemia, pituitary disease, cold intolerance, and constipation.
• Malignancy and pulmonary or central causes: Review smoking, cough, weight loss, pain, recent brain disease, infection, and surgery, guided by probability rather than fear.
• Osmotic demyelination risk: Identify very low sodium, hypokalemia, malnutrition, alcohol use disorder, advanced liver disease, and other factors associated with vulnerability.

Ruth's neighbor provides a medication list and baseline function. With Ruth's permission once cognition improves, the team contacts the pharmacy and clinic to verify the start date and earlier laboratory values. This collateral information changes both diagnosis and prevention.

Diagnostic strategy#

Treat severe symptoms while obtaining classification tests#

Because Ruth has substantial encephalopathy, vomiting, and fluctuating arousal with profound hyponatremia, monitored hypertonic saline treatment begins according to the institution's emergency protocol. The goal is a small prompt sodium rise sufficient to reduce cerebral edema and improve severe symptoms, not immediate normalization. Serum sodium is checked frequently enough to observe the response between treatment steps. Airway, cardiac rhythm, oxygenation, and seizure readiness are maintained.

Before substantial fluid changes when feasible, the team obtains measured serum osmolality, urine osmolality, urine sodium and potassium, glucose, urea, creatinine, calcium, magnesium, liver measures, uric acid, thyroid testing, and cortisol. Emergency treatment is not delayed if urine collection or a specialized assay is unavailable. Blood and urine results are time-stamped relative to fluids and medication withdrawal because interpretation changes after treatment.

Classify tonicity first#

Measured serum osmolality is low, confirming hypotonic hyponatremia. Glucose is normal, and there is no laboratory concern for a major lipid or protein artifact. This makes true excess of water relative to exchangeable sodium and potassium the relevant physiology.

Urine osmolality is 560 mOsm/kg, showing that the kidney is not excreting maximally dilute urine despite hypotonic plasma. Urine sodium is 68 mmol/L. That result might suggest SIADH in a patient not taking a diuretic, but active thiazide use increases urinary sodium and weakens volume inference. The concentrated urine indicates ongoing vasopressin effect or impaired dilution; it does not identify the cause by itself.

Search for dangerous alternatives and contributing conditions#

Morning cortisol is not low in a range that raises immediate concern, and subsequent endocrine interpretation does not support adrenal insufficiency. Thyroid testing does not show severe hypothyroidism. Liver studies, examination, and chest imaging do not suggest cirrhosis, heart failure, or a pulmonary mass. Kidney function is adequate to permit a water diuresis if antidiuretic stimuli resolve. No focal neurologic finding emerges, and cognition begins to improve with the initial controlled rise, lowering concern for a separate acute structural brain lesion.

The diagnostic strategy remains revisable. An apparently reassuring cortisol collected after exogenous glucocorticoid, at an uninterpretable time, or during critical illness might not settle the question. Likewise, normal chest imaging would not exclude every malignant source of SIADH if hyponatremia persisted after medication withdrawal.

Progressive results and interpretation#

After carefully protocolized hypertonic treatment, sodium rises from 109 to 114 mmol/L over several hours. Ruth becomes easier to arouse, follows commands, and recognizes her neighbor. The headache improves. Hypertonic therapy is paused because the immediate neurologic objective has been achieved. The thiazide is stopped. The antidepressant is held while its contribution and psychiatric history are reviewed. Potassium replacement begins with the understanding that intracellular potassium repletion can increase serum sodium.

The team initially provides a limited amount of isotonic fluid because examination suggests volume depletion, with bedside reassessment rather than an open-ended order. Nausea is treated and oral intake remains supervised. Urine output, previously low, suddenly increases. Over the next three hours she produces several liters of pale urine. Repeat urine osmolality falls markedly. Sodium reaches 118 mmol/L sooner than intended.

This is the key transition. The kidney has shifted from retaining water to excreting electrolyte-poor water after the thiazide was stopped, nausea improved, and effective circulating volume began to recover. The sodium is now rising from endogenous water loss, not merely from the sodium content of administered fluid. Stopping saline alone may not halt it.

Ruth has several features that increase concern about overcorrection: profound initial hyponatremia, uncertain duration, hypokalemia, and low recent nutritional intake. Nephrology is already involved. The team uses a specialist-directed strategy to stop the water diuresis with desmopressin and replace a calculated portion of electrolyte-free water. Exact administration depends on current sodium, urine output, glucose, kidney function, and the verified local protocol. Sodium is measured repeatedly during relowering and stabilization.

The intervention brings the trajectory back within the agreed correction ceiling. Ruth does not develop seizure, new weakness, dysarthria, swallowing difficulty, or a delayed movement disorder. By the next day she is oriented and conversing normally. Potassium and magnesium normalize under monitoring. The urine remains less concentrated than on admission, consistent with removal of the earlier antidiuretic stimuli.

The combined evidence supports thiazide-associated hyponatremia with mixed volume, low-solute, water-intake, and nausea contributions. The long-standing antidepressant may have reduced reserve but is less convincing as the sole cause after four stable years. That distinction matters for future psychiatric treatment, although any restart still requires individualized risk review and electrolyte monitoring.

Management plan#

Rescue the brain without normalizing sodium rapidly#

Severe or moderately severe neurologic symptoms justify prompt hypertonic saline in a closely monitored environment. Treatment is given in discrete protocolized steps with reassessment of symptoms and sodium. The goal is a modest early increase, commonly enough to reverse cerebral edema, followed by cause-specific treatment and strict limits on further correction. The exact solution, access, and administration sequence follow current institutional guidance.

If a seizure occurs, airway and seizure management proceed alongside hypertonic treatment. A sodium value should never postpone standard resuscitation. Conversely, a very low number in an awake, minimally symptomatic patient does not justify uncontrolled normalization. Symptoms, chronicity, and risk must remain linked.

Stop contributors and treat the mechanism#

The thiazide-like diuretic is permanently removed from the active medication list and recorded as a severe adverse reaction, not merely marked "inactive." Nonsteroidal anti-inflammatory use, water advice, low intake, and nausea are addressed. The antidepressant decision is made with primary care and mental health clinicians, weighing prior benefit, alternative agents, recurrence risk, and monitoring rather than assuming every possible contributor must remain stopped forever.

Volume depletion is corrected cautiously. Isotonic fluid can be appropriate in hypovolemic hyponatremia, but once vasopressin falls it can unleash a brisk water diuresis. In SIADH physiology, isotonic saline may fail to correct or may worsen hyponatremia when the kidney excretes sodium in concentrated urine while retaining water. This is why classification and repeated urine assessment matter.

Fluid restriction is not the emergency treatment for severe hyponatremic encephalopathy. It may have a role in persistent SIADH after stabilization, but effectiveness depends on urine concentration, thirst, solute intake, and feasibility. Urea, vasopressin antagonists, loop diuretics, and other chronic strategies belong to selected patients under experienced supervision. A vasopressin antagonist is not used to rescue acute severe symptomatic hyponatremia and can create excessive correction.

Control correction, including the hidden contributions#

The sodium trajectory includes every input and output: hypertonic and isotonic fluids, oral water, urine water and electrolytes, potassium replacement, nutrition, vomiting, and changing kidney function. A spreadsheet can help, but formulas are estimates and cannot substitute for repeated measurement when physiology is changing rapidly.

If sodium rises faster than the agreed limit, the team stops causative infusions, identifies water diuresis, and considers desmopressin with electrolyte-free water under specialist direction. Desmopressin can be used reactively or as part of a proactive controlled strategy in selected high-risk cases. It also creates water-retention risk, so fluids, urine, and sodium require continued surveillance. Relowering is an active clinical intervention, not an admission of failure.

Potassium replacement is planned as part of correction because retained potassium contributes to effective body solute and can raise measured sodium. Nutrition is advanced thoughtfully because restoring protein and solute can increase renal water excretion. Blood draws are coordinated to avoid gaps during the most dynamic period.

Replace the blood-pressure plan#

Ruth's hypertension is reassessed after recovery using repeated standardized measurements and home data rather than the single rushed visit that prompted intensification. An alternative antihypertensive strategy is chosen based on comorbidities, orthostasis, kidney function, and preferences. The plan includes a laboratory check after relevant medication changes and a named clinician responsible for acting on the result.

Escalation, referral, and safety net#

Seizure, coma, respiratory compromise, worsening confusion, acute focal neurologic findings, or signs of cerebral herniation require immediate critical care. Profound hyponatremia with severe symptoms belongs in an environment that can deliver hypertonic therapy, frequent sodium measurement, accurate urine output, and rapid response to overcorrection.

Nephrology, endocrinology, or an experienced acute-medicine specialist should be involved early when sodium is profound, chronicity is uncertain, symptoms are severe, the cause is mixed, urine output rises suddenly, correction exceeds the intended trajectory, adrenal disease is possible, or advanced therapies are considered. Pharmacy supports medication chronology, interaction review, and adverse-reaction documentation.

During hospitalization, new dysarthria, swallowing difficulty, weakness, behavioral change, movement disorder, or reduced consciousness after initial improvement raises concern for osmotic demyelination or another neurologic process. Osmotic demyelination may be delayed, and normal early imaging does not always exclude it. Neurology and magnetic resonance imaging are considered according to the clinical course.

After discharge, recurrent confusion, vomiting, seizure, severe headache, marked unsteadiness, or reduced responsiveness requires emergency assessment. Increasing fatigue, nausea, new falls, or cognitive slowing after any medication change warrants prompt electrolyte testing. Ruth is told not to self-treat these symptoms by drinking large amounts of water or taking salt supplements without clinical assessment.

Communication, shared decisions, and equity#

The clinician explains the paradox in plain language: "Your blood had too much water for the amount of sodium and potassium in it. That made water move into brain cells, which contributed to the confusion. We raised the sodium a little to protect your brain, but raising it too fast can also injure the brain. That is why we checked the blood and urine so often even after you began to feel better."

The medication conversation avoids blame. Ruth followed two common messages: take the new tablet and drink more water. Neither instruction included a laboratory plan, a practical range for fluid intake, or warning symptoms. The adverse event is therefore treated as a systems issue. The discharge list explains why the thiazide should not be restarted and identifies alternative medicine names that belong to the same risk conversation.

Depression treatment receives equal respect. Abruptly framing the antidepressant as "the culprit" could destabilize mental health and is not supported by the chronology. Ruth participates in deciding whether to resume it, change it, or use another approach, with safety monitoring. Her mood, sleep, and social isolation are assessed after the acute delirium clears.

Access shaped the event. The clinic offered a delayed virtual visit to a confused older adult without arranging laboratory testing or verifying digital access. Future pathways include same-day triage triggers for new confusion, vomiting, and recent diuretic initiation. Ruth receives written instructions in large print, and her neighbor participates only with Ruth's consent. Transportation for laboratory testing and the cost of home blood-pressure equipment are addressed.

Nutrition advice is culturally and economically realistic. The team does not respond to hyponatremia with a permanent high-salt diet. A dietitian helps restore adequate protein and solute while respecting hypertension and food preferences. Advice about drinking follows thirst, weather, illness, and clinician direction rather than a universal bottle count.

Follow-up and contingencies#

The discharge summary records the baseline and lowest sodium, the correction trajectory, neurologic symptoms, medication chronology, presumed mixed mechanism, overcorrection response, and medicines stopped. The thiazide reaction is entered in the allergy or adverse-reaction field and the pharmacy profile. The summary names who will recheck sodium, potassium, kidney function, blood pressure, and mental status.

Early outpatient review verifies stable electrolytes and intake after the controlled hospital environment. Additional testing depends on whether sodium remains normal without the thiazide and after psychiatric medication decisions. Persistent hypotonic hyponatremia would reopen evaluation for SIADH, endocrine disease, kidney or liver disease, pulmonary pathology, central nervous system disease, or ongoing low-solute intake.

Contingency branches include:

• Sodium falls again after discharge: Confirm tonicity, repeat urine studies at an interpretable time, review every medicine and fluid change, and reassess adrenal, thyroid, pulmonary, neurologic, renal, and nutritional causes.
• Blood pressure rises without the thiazide: Use repeated standardized measurements and choose an alternative class rather than accepting recurrent hyponatremia risk.
• The antidepressant is restarted: Arrange an explicit electrolyte and symptom-monitoring plan, especially after any dose change or intercurrent illness.
• Urine output suddenly increases during any future admission: Check sodium promptly and consider whether removal of an antidiuretic stimulus is causing a rapid correction.
• New neurologic symptoms appear days later: Evaluate urgently for osmotic demyelination, stroke, seizure, or another cause even if sodium is now normal.
• Oral intake declines during illness: Contact a clinician early for medicine and fluid guidance rather than following a generic instruction to drink as much as possible.

The team also reviews fall risk, bone health, and home supports. Hyponatremia can impair gait and attention before dramatic symptoms appear, and recurrence prevention protects more than the laboratory number.

Reasoning traps and alternative pathways#

• Treating the sodium number without assessing symptoms: Severe neurologic features determine emergency treatment, while a low number alone does not authorize uncontrolled normalization.
• Assuming every low sodium is hypotonic: Hyperglycemia, other effective osmoles, and laboratory artifacts require a different interpretation.
• Calling a diuretic-treated patient SIADH from one urine sodium: Thiazides distort urine sodium and can create an SIADH-like biochemical pattern.
• Giving a large isotonic-fluid order and checking tomorrow: Reversal of hypovolemia can abruptly suppress vasopressin and cause rapid water loss.
• Stopping saline and assuming correction will stop: Once dilute polyuria begins, sodium can continue rising from endogenous water loss.
• Forgetting potassium: Potassium replacement contributes to effective solute correction and can amplify the sodium rise.
• Correcting to normal because cognition improved: Initial improvement signals that the rescue goal may have been reached, not that normalization should accelerate.
• Using fluid restriction as emergency therapy for encephalopathy: Fluid restriction acts too slowly for severe symptoms and does not control immediate cerebral edema.
• Restarting the thiazide under a different brand name: Class re-exposure can recreate the problem, so documentation must be specific and visible.
• Blaming the patient for drinking water: Advice, access, medication monitoring, diet, and symptom triage all contributed to the event.

An alternative pathway would emerge if serum osmolality were normal or high, if severe hyperglycemia explained translocational hyponatremia, or if a direct laboratory method showed pseudohyponatremia. Hyperkalemia, hypoglycemia, weight loss, and refractory hypotension would elevate adrenal crisis. Edema and ascites would favor hypervolemic physiology. Maximally dilute urine would move primary polydipsia or low-solute intake toward the center. Persistent concentrated urine after thiazide clearance and restored volume would strengthen SIADH and require a search for its cause.

Evidence limits and what could change#

Hyponatremia guidance agrees on the need to treat severe neurologic symptoms promptly and avoid excessive correction, but organizations differ in exact bolus formats, correction ceilings, and terminology. Local protocols should choose one internally consistent pathway. Mixing pieces from several guidelines at the bedside can produce duplicate treatment or contradictory targets.

The SALSA trial compared rapid intermittent and slow continuous hypertonic saline strategies in symptomatic patients and found both could be used safely with close monitoring, while intermittent treatment more often achieved an early target and required less relowering. The trial does not eliminate the need to individualize for chronicity, very low sodium, urine output, and osmotic demyelination risk.

Desmopressin strategies are supported largely by observational evidence, physiologic rationale, and expert practice rather than large definitive trials across every phenotype. Proactive use may improve control in selected high-risk patients, but it can also prolong hyponatremia or cause water retention if fluid administration is not managed. The team using it must understand the mechanism and monitor closely.

Contemporary cohorts show that rapid correction is relatively common while diagnosed osmotic demyelination is rare. That observation does not make rapid correction acceptable. The highest-risk patients are uncommon, diagnostic coding may miss cases, magnetic resonance findings can be delayed, and the consequence can be devastating. Reported cases also occur within nominal correction limits, emphasizing the importance of individual vulnerability.

Thiazide studies show a marked early risk after initiation but also later cases during superimposed illness. No single electrolyte-monitoring interval detects every case. Monitoring schedules should reflect baseline sodium, age, body size, comorbidities, concomitant medicines, intake, and symptoms, and must include a route for urgent reassessment.

Future evidence may refine correction limits, identify biomarkers of brain vulnerability, and clarify when proactive desmopressin is superior to reactive use. Until then, frequent clinical and laboratory reassessment remains the central safety system.

Key points#

• Confirm hypotonicity and interpret urine studies in the context of medication and treatment timing.
• Severe neurologic symptoms require prompt controlled hypertonic treatment even before the full cause is known.
• Thiazide-associated hyponatremia can look hypovolemic, SIADH-like, or mixed.
• Anticipate a brisk water diuresis after stopping the cause, relieving nausea, restoring volume, or improving nutrition.
• Include potassium and nutrition in the correction calculation and respond actively to an excessive trajectory.
• Prevent recurrence through visible adverse-reaction documentation, an alternative blood-pressure plan, laboratory follow-up, and practical patient education.

Sources#

1. European Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia
2. Society for Endocrinology Emergency Management of Symptomatic Hyponatraemia
3. Hyponatraemia Treatment Standard 2024
4. Diagnosis Evaluation and Treatment of Hyponatremia Expert Panel Recommendations
5. SALSA Randomized Clinical Trial of Hypertonic Saline Strategies
6. Thiazide-Associated Hyponatremia Report of the Hyponatremia Registry
7. Association Between Newly Initiated Thiazides and Hospitalization for Hyponatremia
8. Hypertonic Saline and Desmopressin Strategy for Severe Hyponatremia
9. Osmotic Demyelination Syndrome in Patients Hospitalized With Hyponatremia
10. Hyponatremia Correction and Osmotic Demyelination Risk Meta-analysis
11. Endocrine Society Primary Adrenal Insufficiency Guideline